GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (NSE:NEULANDLAB) » Definitions » Cyclically Adjusted Price-to-FCF

Neuland Laboratories (NSE:NEULANDLAB) Cyclically Adjusted Price-to-FCF : 362.79 (As of Jun. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Neuland Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2024-06-09), Neuland Laboratories's current share price is ₹6290.80. Neuland Laboratories's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar24 was ₹17.34. Neuland Laboratories's Cyclically Adjusted Price-to-FCF for today is 362.79.

The historical rank and industry rank for Neuland Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

NSE:NEULANDLAB' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 14.75   Med: 125.68   Max: 437.65
Current: 365.61

During the past 13 years, Neuland Laboratories's highest Cyclically Adjusted Price-to-FCF was 437.65. The lowest was 14.75. And the median was 125.68.

NSE:NEULANDLAB's Cyclically Adjusted Price-to-FCF is ranked worse than
96.89% of 322 companies
in the Drug Manufacturers industry
Industry Median: 31.865 vs NSE:NEULANDLAB: 365.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Neuland Laboratories's adjusted free cash flow per share data of for the fiscal year that ended in Mar24 was ₹91.588. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₹17.34 for the trailing ten years ended in Mar24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Neuland Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Neuland Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories Cyclically Adjusted Price-to-FCF Chart

Neuland Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.76 104.58 183.86 118.21 364.60

Neuland Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.21 - - - 364.60

Competitive Comparison of Neuland Laboratories's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuland Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Neuland Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Neuland Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=6290.80/17.34
=362.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuland Laboratories's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar24 is calculated as:

For example, Neuland Laboratories's adjusted Free Cash Flow per Share data for the fiscal year that ended in Mar24 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar24 (Change)*Current CPI (Mar24)
=91.588/153.0345*153.0345
=91.588

Current CPI (Mar24) = 153.0345.

Neuland Laboratories Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -2.660 97.163 -4.190
201603 28.717 102.518 42.867
201703 -2.193 105.196 -3.190
201803 -109.664 109.786 -152.864
201903 5.399 118.202 6.990
202003 6.660 124.705 8.173
202103 65.444 131.771 76.005
202203 -29.070 138.822 -32.046
202303 133.346 146.865 138.948
202403 91.588 153.035 91.588

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Neuland Laboratories  (NSE:NEULANDLAB) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Neuland Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuland Laboratories (NSE:NEULANDLAB) Business Description

Traded in Other Exchanges
Address
Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (NSE:NEULANDLAB) Headlines

No Headlines